1222 / 1578
Fekrazad M H et al. JCO 2
007;25:5024-5026
Erlotinib 150 mg
60y, f, NSCLC IV, multiple BM
3 months after WBRT (30 Gy):
8 months later
EGFR inhibitors in NSCLC
|
|
1222 / 1578
Fekrazad M H et al. JCO 2
007;25:5024-5026
Erlotinib 150 mg
60y, f, NSCLC IV, multiple BM
3 months after WBRT (30 Gy):
8 months later
EGFR inhibitors in NSCLC